You do not have permission to access this chart.
Please Sign Up or Login

About:

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and novel oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas. The company is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

4

Address:

Xenetic Biosciences, Inc. 40 Speen Street Suite 102 Framingham MA 01701 United States

Website:

http://www.xeneticbio.com

Phone:

781-778-7720

Leave a comment

Your email address will not be published. Required fields are marked *